We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SMBC:NASDAQSouthern Missouri Bancorp, Inc. Analysis

Data as of 2026-09-13 - not real-time

$73.26

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

Southern Missouri Bancorp, Inc. is priced at $73.26, and its moving averages give no clean directional read — the structure is neutral. Across the trailing 30 sessions it lost 5.3%. RSI sits at 40.9, which reads as neutral, and MACD momentum is bearish. Price has been bracketed by support at $72.12 and resistance at $77.50.
The shares look undervalued, trading on 11.4 times earnings below a sector average of 16.2. Consensus targets land 14.2% above where the shares trade now. Revenue is growing at 7.7% on a 38.0% profit margin. The 1.39% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 13.3%, a beta of 0.42 and a maximum drawdown of 14.9%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 5 out of 10.

Top Market Events

Southern Missouri Bancorp SMBC delivered earnings and revenue surprises of +10.Yahoo Finance1monSouthern Missouri Bancorp, Inc.Seeking Alpha1monSouthern Missouri Bancorp: Still Attractive Despite Premium To Tangible Book ValueIn the second...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Trading above the 200-day average of 67.57
  • MACD momentum is negative
  • 30-day price change of -5.3%

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 11.4 versus sector average of 16.2
  • Trading above the 200-day average of 67.57
  • Analyst targets imply +14.2% versus the current price

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 11.4 versus sector average of 16.2
  • Analyst targets imply +14.2% versus the current price
  • Profit margin of 38.0% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth7.70%
Profit Margin37.97%
P/E Ratio11.4
ROE12.65%
ROA1.40%
P/B Ratio1.4
Op. Cash Flow$80.5M
Industry P/E16.2

Technical Analysis

TrendNeutral
RSI40.9
Support$72.12
Resistance$77.50
MA 20$74.10
MA 50$75.79
MA 200$67.57
MACDBearish
VolumeStable
Fear & Greed Index93.14

Valuation

Fair Value$80.14
Target Price$83.67
Upside/Downside14.21%
GradeUndervalued
TypeValue
Dividend Yield1.39%

Risk Assessment

Beta0.42
Volatility13.32%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.